Proxymetacaine shows efficacy in pain control after cross-linking

FRANKFURT, Germany — Proxymetacaine drops are one strategy to reduce postoperative pain after epi-off cross-linking, according to a study conducted at a U.K. hospital.
Pain management is one of the challenges of epi-off CXL and can be particularly acute in pediatric patients and patients with intellectual disabilities, Mohamed Elghobaier, MD, said at the ESCRS winter meeting.
“Currently, there is no universally accepted strategy to deal with postoperative pain,” he said.
With only one case of corneal toxicity found in the literature, proxymetacaine hydrochloride is known for

Full Story →